Your browser doesn't support javascript.
loading
Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses.
Akhtar, Marjahan; Chowdhury, Mohiul I; Bhuiyan, Taufiqur R; Kaim, Joanna; Ahmed, Tasnuva; Rafique, Tanzeem A; Khan, Arifuzzaman; Rahman, Sadia I A; Khanam, Farhana; Begum, Yasmin A; Sharif, Mir Z; Islam, Laila N; Carlin, Nils; Maier, Nicole; Fix, Alan; Wierzba, Thomas F; Walker, Richard I; Bourgeois, A Louis; Svennerholm, Ann-Mari; Qadri, Firdausi; Lundgren, Anna.
Afiliação
  • Akhtar M; icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
  • Chowdhury MI; icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
  • Bhuiyan TR; icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
  • Kaim J; GUVAX (Gothenburg University Vaccine Research Institute), Dept. of Microbiology and Immunology, Inst. of Biomedicine, University of Gothenburg, Sweden.
  • Ahmed T; icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
  • Rafique TA; icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
  • Khan A; icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
  • Rahman SIA; icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
  • Khanam F; icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
  • Begum YA; icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
  • Sharif MZ; icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
  • Islam LN; Dept. of Biochemistry and Molecular Biology, University of Dhaka, Bangladesh.
  • Carlin N; Scandinavian Biopharma, Solna, Sweden.
  • Maier N; PATH, Washington, DC, USA.
  • Fix A; PATH, Washington, DC, USA.
  • Wierzba TF; PATH, Washington, DC, USA.
  • Walker RI; PATH, Washington, DC, USA.
  • Bourgeois AL; PATH, Washington, DC, USA.
  • Svennerholm AM; GUVAX (Gothenburg University Vaccine Research Institute), Dept. of Microbiology and Immunology, Inst. of Biomedicine, University of Gothenburg, Sweden.
  • Qadri F; icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.
  • Lundgren A; GUVAX (Gothenburg University Vaccine Research Institute), Dept. of Microbiology and Immunology, Inst. of Biomedicine, University of Gothenburg, Sweden. Electronic address: anna.lundgren@microbio.gu.se.
Vaccine ; 37(37): 5645-5656, 2019 09 03.
Article em En | MEDLINE | ID: mdl-30473185

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Escherichia coli / Infecções por Escherichia coli / Escherichia coli Enterotoxigênica / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Vaccine Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Bangladesh País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Escherichia coli / Infecções por Escherichia coli / Escherichia coli Enterotoxigênica / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Vaccine Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Bangladesh País de publicação: Holanda